Clinical trial Recruiting at 1 site Interventional Ages 0 Days to 28 Days

Support for parents of children with congenital heart disease during surgery

Official title: Evaluation of the Feasibility of Support for the Management of Parental Stress in Surgical Resuscitation of Congenital Heart Diseases

Run by University Hospital, Bordeaux · NCT06884046 · Data updated 2026-11-12

This study is testing a new support program to see if it can help reduce stress for parents of babies with congenital heart disease during their surgery.

More Congenital Heart Disease trials

Quick facts

Study typeInterventional
Ages0 Days to 28 Days
SexAll
Enrollment40 (estimated)
SponsorUniversity Hospital, Bordeaux
Academic / other
Locations1 site (Pessac, France)
StatusRecruiting
StartedFebruary 6, 2025
Main results expectedFebruary 6, 2027
Study endsFebruary 6, 2027
Registry record updatedMarch 19, 2025
Trial IDNCT06884046 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are parents of fetuses diagnosed with congenital heart disease who will undergo surgery within the first 28 days of life.

Probably not a fit

Parents who do not understand or read French or those with major psychiatric disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates a personalized support model aimed at reducing parental stress during the neonatal surgical management of congenital heart disease. It focuses on providing comprehensive, multidisciplinary care starting from the antenatal period, addressing the unique challenges faced by families. The intervention includes consultations with a paramedical team and tailored support projects to meet the specific needs of parents. The effectiveness of this approach will be assessed through parental stress evaluations at various stages of the care journey.

Why it matters

Potential benefit: If successful, this approach could significantly improve the well-being of parents and enhance the neurodevelopmental outcomes for their children.

How similar studies have gone: While there is limited data on similar personalized support models, the approach is innovative and may provide new insights into managing parental stress in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Parents whose fetus has congenital heart disease diagnosed in antenatal, which will be operated in the neonatal period (between 0 and 28 days of life) within our sector.
* Parents followed in the congenital heart disease sector of the University Hospital of Bordeaux as soon as the diagnosis is announced in antenatal.
* Free, informed and signed written consent of the couple or single mother in a single parent setting or by a third person (in case of physical disability of the participant) and the investigator (no later than the day of inclusion and before any examination required by the research).
* Person affiliated or beneficiary of a social security scheme (excluding AME).
* Parents with parental authority.

Exclusion Criteria:

* Parents who do not understand or read French and cannot be accompanied by a third party for translation.
* Parents with major psychiatric disorders.
* Parents deprived of liberty due to ongoing legal proceedings.
* Parents under guardianship or curatorship or unable to personally express consent.

Where it's running

  • Hôpital Cardiologique Haut-Lévêque
    Pessac, France, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.